AccurKardia Granted Patent for AI-Driven ECG Detection of Cardiac Amyloidosis
Patent establishes IP across all major amyloidosis subtypes and transforms the standard 12-lead ECG into a screening tool for one of cardiology’s most underdiagnosed diseases NEW YORK–(BUSINESS WIRE)–AccurKardia, Inc., an ECG analytics software company focused on establishing ECG as a... Read More →
From Concept to Clinic: ResQFoam™ Marks a First-in-Human Milestone in Trauma Care
Patient Stories: How MedTech Innovator alumni are transforming lives At MedTech Innovator we empower healthtech companies to bring groundbreaking solutions to patients in need. Our Patient Stories series highlights the real-world clinical impact of the companies we support—showcasing how their... Read More →
Cardiosense Receives FDA De Novo Classification for Novel Cardiac Technology Designed to Improve Care for Patients with Heart Failure
This is the first noninvasive, AI-powered tool that provides a critical heart pressure reading for patients with heart failure CHICAGO–(BUSINESS WIRE)–Cardiosense, a healthcare technology company focused on heart failure care, today announced that the U.S. Food & Drug Administration (FDA)... Read More →
Arsenal Medical Receives FDA IDE Approval for the RADIANT Pivotal Trial of NeoCast™ in Chronic Subdural Hematoma
A randomized, controlled study of a novel liquid embolic, NeoCast, adjunctive to surgery WALTHAM, Mass. – May 21, 2026 Arsenal Medical, a clinical-stage company developing innovative biomaterial-based devices, announced that the U.S. Food and Drug Administration (FDA) has granted Investigational... Read More →
EpiCypher and New England Biolabs Expand Strategic Partnership to Advance Epigenomics Research
DURHAM, N.C. and IPSWICH, Mass., May 19, 2026 /PRNewswire/ — EpiCypher® and New England Biolabs® (NEB®) today announced an expanded strategic partnership to co-develop next-generation tools for epigenomics research. Building on a successful track record of collaboration, the partnership will... Read More →
Cerillo and Hamilton Company to Join Forces for Expanded Detection and Analysis Capabilities
RENO, NV and CHARLOTTESVILLE, VA – May 18, 2026 – Hamilton Company and Cerillo today announced that they will be joining forces in a strategic combination that unites Hamilton’s global leadership in liquid handling and automation with Cerillo’s innovative compact... Read More →
What You Can (and Can’t) Do to Improve Your Bone Health featuring Osteoboost Health
But we may be on the brink of a new era in preventative treatment. There is promising new research that looks at a “biological switch,” normally triggered by exercise, that helps keep bones strong—offering a potential path for drugs that... Read More →
Aurie Receives FDA De Novo Grant for First Automated Safely Reusable Intermittent Urinary Catheter System
Company announces appointment of Manu Varma to Board of Directors, Dr. Christopher Elliott to Scientific Advisory Board, and Sergey Grigoryants to Chief Technology Officer SYRACUSE, N.Y., May 11, 2026 /PRNewswire/ — Aurie announced that the Aurie Reusable No-Touch Intermittent Catheter... Read More →
Bright Uro Receives FDA Clearance For Glean® Abdominal Sensor
IRVINE, Calif., May 7, 2026 /PRNewswire/ — Bright Uro, a medical device company with a mission to transform care for lower urinary tract dysfunction (LUTD) through innovations in urodynamics, today announced that the U.S. Food and Drug Administration (FDA) has... Read More →
Mobia Medical plans IPO
The neurostimulation device company intends to offer 10 million shares for between $14 and $16 each. Mobia said its Vivistim System, which received premarket approval in 2021, is the only approved solution for chronic ischemic stroke survivors with moderate to... Read More →